Measure better
Healthcare
Performance
With over 70% of medical decisions based on test results, laboratory diagnostics need to be considered as an integrated medical discipline.1
Lab Performance Benchmarking aids an organisation to measure and understand where it is positioned amongst its peers, how far it needs to go before it reaches the top and what efficiencies can be made to help it achieve a measurably better healthcare performance.
The Lab Performance Benchmarking initiative from Core Diagnostics at Abbott focuses on best practices to identify ‘next’ practices and provides laboratories taking part with the knowledge they need to strive for continuous lab performance improvement, against key performance indicators (KPIs), by enabling identification of areas that need to be adapted or modified in order to better meet customer needs.
.png)
"It is quite reassuring that we are very well placed among our peers and that
our strategic input is accurate, however, there are a lot of drivers to focus more on efficiency.
In particular, we should drive the digital transformation forward."
Dr. Jyoti shetye,
Laboratory operations director, mediclinic group (uae)
"The Laboratory Performance Benchmarking initiative gives an important perspective on our Service, analyzed through an intelligent and very practical filter. Completing the survey has given many examples of how we can implement to achieve levels of process control and excellence. Realizing where we are is the first step in knowing where we want to go."
Drª helena ferreira da silva,
Vdireção serviço de patologia clínica, chma, portugal
Abbott talked to 773 laboratories from 39 countries across Europe, Middle East and Africa (EMEA).
This Lab Performance Benchmarking initiative aims to provide laboratories with a means to understand how they compare to peers, as well as enabling them to better position their value to clinical and non-clinical decision makers responsible for managing partnerships with laboratories.
Data leads to
Powerful insights
Find out how your lab compares on metrics such as clinician expectation time (CET),
turnaround time (TAT), ISO 15189 Accreditation,
Lean Six Sigma, staff productivity and so much more.
The diagnosis cycle starts before samples arrive at the laboratory yet monitoring often doesn’t begin until the samples arrive. For clinicians, their waiting time starts as soon as they make a request, this is known as clinician expectation time (CET).2
ISO 15189 accreditation underpins confidences in the quality of medical laboratories through a process that verifies integrity, impartiality, and competence. Accreditation to ISO 15189 varies across EMEA with largest uptake in France.2
Laboratories across EMEA report a shortage of staff. This shortage is more pronounced for higher skilled staff compared to lower skilled staff and more obvious in the commercial than in the hospital sector.2
Staff productivity in labs with automation for clinical chemistry, immunoassay and hematology process higher quantities of samples and tests per full-time equivalent (FTE).2
Laboratory performance as a relative concept needs repetitive benchmarking for continuous improvement of laboratory procedures and medical processes. The aim of this study was to examine the utility of a specific combination of indicators and survey-based data collection approach, and to establish a global benchmarking dataset of laboratory performance for decision makers in healthcare institutions.
The aim of this study was to establish a good practice approach towards benchmarking for three key dimensions of medical laboratory performance and to generate a tentative snapshot of the current state of the art in the region of Europe, Middle East, and Africa (EMEA). Altogether, the need for stronger integration of laboratories into the clinical care process became apparent and should be a main trajectory of future laboratory management.
Around the globe operational efficiency of diagnostic laboratories plays a key role to assure patient safety, but how do laboratories achieve this and how do they compare to each other? The aim of this study was to design and pilot a questionnaire in Germany, Switzerland, and Austria to address and compare key aspects of diagnostic laboratory management.
Understanding where your Laboratory stands and how it compares to its peers is important to stay ahead! Listen to Laboratory Professionals talk about their experience with Laboratory Performance Benchmarking, and how it helped them make informed decisions, for better healthcare performance.
Hear Dr.Huf’s (Medical Director at Vienna Healthcare Group – Clinic Hietzing, Austria) views on why he believes Laboratory Benchmarking is important for evidence-informed decision making in healthcare management.
See how the Laboratory at Aberdeen Royal Infirmary compares on metrics such as sample volume, pre-analytical automation and advanced IT to monitor reagent supply.
The Lab Performance Benchmark report aims to help labs to stay ahead by first illustrating where they stand when compared to their peers. It enables labs to understand gaps in current provision to identify areas where they can differentiate to achieve business goals and outperform peers.
Our extensive assay menu helps physicians make timely, informed decisions throughout the continuum of care.
Learn about the innovative total laboratory automation solution with proven technology and flexibility to meet your goals.
Discover how Alinity uses powerful technology to help redefine and improve operational productivity and confidence in your laboratory.
REFERENCES
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
